Officials with TransEnterix announce that surgeons from the United States and Paraguay have successfully performed firstinman studies of its revolutionary singleincision, singleport, fourchannel laparoscopic surgical platform called the SPIDER™ System.

The SPIDER System short for Single Port Instrument Delivery Extended Reach allows surgeons to perform minimally invasive abdominal surgeries entirely through the umbilicus, leaving no visible scar. Its the first singleport system to offer surgeons true triangulation and other critical techniques common in multiport laparoscopy.

Fewer complications, faster full recovery, less postsurgical pain and an improved aesthetic result are potential benefits of singleport technology. Conventional laparoscopic surgery typically involves three to five incisions, which leave small scars in a patients abdomen. Surgeons in the United States perform more than 2.5 million laparoscopic procedures each year. TransEnterix expects to market its platform early next year.

In the TransEnterix firstinman studies, surgeons successfully used the SPIDER System to perform cholecystectomies gallbladder removals on seven patients in Paraguay. One of the surgeons was American; the other surgeon was Paraguayan. The patients were Paraguayans who previously had received medical diagnoses requiring surgical removal of their gallbladders.

Todd M. Pope, president and CEO, said the procedures went extremely well, adding that surgeons confirmed that cholecystectomies performed with the SPIDER System took approximately the same amount of time as standard laparoscopic procedures.

“And thats a critical point to make because surgeons wont be interested in new technology that requires that they spend more time in the operating room technological advances should make their jobs easier, not harder,” Pope said. “As we knew from having worked so closely with TransEnterixs expert surgeon advisers, the SPIDER System is extremely user friendly. Surgeons who are comfortable with current laparoscopic techniques will adapt easily to our new platform.”

Dr. Aurora Pryor, a surgeon who serves on the TransEnterix Scientific Advisory Board, oversaw the firstinman studies in Paraguay. She said the SPIDER System performed exactly as expected.

“I was pleased with how straightforward the system was to set up and use,” she said. “Two of the patients had acute inflammation and with the SPIDER System, I was able to complete their procedures safely and efficiently. The postoperative results were excellent the patients scars were hidden and the patients reported less pain than is typical with standard laparoscopic approaches.”

Dr. Héctor Rolando Herrera Cabral is the Paraguayan surgeon who performed two of the cholecystectomies during the firstinman studies. Despite never having seen the SPIDER System before participating in the TransEnterix firstinman cases, the surgeon said he was quickly able to use it.

“My experience was very positive,” he said. “What was most impressive is how patients who had a cholecystectomy with the SPIDER System did not report any pain the day after the surgery or said their pain was minimal, whereas patients who undergo conventional laparoscopic surgery typically report mild pain. The aesthetic result is fantastic the wound heals without leaving marks on the abdomen and patients report total satisfaction.”

Source

Botox is one of the many trade names for the neurotoxic protein called botulinum toxin that is produced by the bacterium Clostridium botulinum. In large doses, the protein causes botulism, a rare paralytic illness often linked to food poisoning.

However, the protein is used in cosmetic medicine to treat moderate to severe brow furrow (glabellar lines), uncontrolled blinking, lazy eye, wrinkles, and facial creases. These procedures use a small amount of diluted botulinum toxin that enables controlled weakening of muscles.

Visit our specialized news sections

Cosmetic Medicine / Plastic Surgery News

Dermatology News

Botulinum toxin is sold commercially under the brand names Botox, BTXA, Dysport, Myobloc, Neurobloc, Xeomin, Botox Cosmetic, and Vistabel. Botox widely used for noncosmetic medical proceduresIn addition to cosmetic use, Botox is used to treat cervical dystonia, writers cramp, excessive sweating, achalasia (an esophagus problem), chronic pain, neuropathy, and migraine headaches.

For people with overactive bladders, Botox can improve their quality of life, say researchers from Kings College London School of Medicine, London, England.

Men with enlarged prostates benefit from Botox injections directly into the prostate, a study at University Medical College, Taiwan found.A possible treatment for some cases of depressionSome studies have indicated that Botox used for aesthetic purposes can help people with mental illness. A study published in Dermatologic Surgery found that treating clinically depressed patients with Botox on the frown lines of their faces actually got rid of their depression.How does Botox work? Botox works to relax the contraction of muscles by blocking nerve impulses. The result is muscles that can no longer contract, and so the wrinkles relax and soften. It usually takes two to four days to see cosmetic improvement and the effects tend to last from four to six months. Most patients require retreatment to remove wrinkles and lines as they begin to reappear, but after each injection the wrinkles return as less severe as the muscles are trained to relaxHow is Botox administered? Botox procedures do not require anesthesia and usually take just a few minutes to perform. The protein is injected into the muscle using a fine needle in order to minimize discomfort and maximize accuracy. It is recommended that patients avoid alcohol for about a week before the procedure. In order to minimize bruising, patients should stop using aspirin and antiinflammatory medications about two weeks before treatment. For cosmetic procedures, a study published in Dermatologic Therapy found that men need a higher dose of Botox than women.Is Botox better than a facelift?According to the American Society of Plastic Surgeons, whether Botox gives better results than a facelift (surgery) depends on the age of the patient. People in their 30s who have had limited exposure to sunlight usually show signs of aging in their eyes and temple area first, with crows feet and some bulging of the eyelid. As they have not lost much volume at this point, fillers or Botox usually smooth out the lines that people want to get rid of.

When people enter their 40s the middle of the face starts to shift as the cheeks lose some of their fat and laugh lines set in. The cheeks become deflated towards the end of the 4th decade, and the jowls start to sag. A combination of Botox as well as minimal lifting procedures will provide the best results.What are the side effects of Botox? The most common side effect of Botox injections is temporary bruising. Other possible side effects includeHeadache Respiratory infection Flu syndrome Blepharoptosis (drooping of the upper eyelid) NauseaIndigestion (heartburn) Doctors in the USA and the UK have reported that some patients “binge” on Botox to the point where their faces look frozen. They refer to the term “Wrinklerexia” when some Botoxdevotees become so obsessed with their wrinklefree image that they start seeing lines where there are none and binge on Botox to obtain a freezeframe face.

NeoStem, Inc. (NYSE Amex NBS), which is pioneering the predisease collection, processing and longterm storage of adult stem cells for future medical need, has filed a patent application claiming the proprietary stem cell technology of Vincent C. Giampapa, M.D., F.A.C.S. relating to cosmetic facial rejuvenation, which NeoStem first licensed in February 2009.

The newest adult stem cell collection center in the NeoStem network, located at the Giampapa Institute for AntiAging Medical Therapy in Montclair, New Jersey, has received, from the state of New Jersey Department of Health and Senior Services, a blood bank license for autologous peripheral blood stem cell collection. This allows the center to open and commence operations, and together with the patent application will serve to significantly advance NeoStems leadership in the antiaging and regenerative medicine arena.

Dr. Giampapa, director of the Giampapa Institute for AntiAging Medical Therapy, is a boardcertified plastic reconstructive surgeon and Assistant Clinical Professor of Plastic and Reconstructive Surgery at the University of Medicine and Dentistry of New Jersey and is one of the first certified antiaging medical physicians in the world. His research and technology comprise a nonsurgical procedure for complete facial rejuvenation that involves injecting pluripotent cells, including stem cells, into the skin of individuals whose skin has lost its firmness and texture due to age. The pluripotent cells stimulate the growth of various cells in the skin, leading to the restoration of the skins firmness and texture. The procedure can be accomplished under local anesthesia in an office setting and typically requires only a week of recovery time.

“NeoStem is very focused on acquiring technologies related to stem cell therapies,” stated Robin Smith, M.D., MBA, NeoStems Chief Executive Officer. “We are especially delighted to strengthen our relationship with Dr. Giampapa, as antiaging technology is one of our key pursuits. Filing a patent for stem cell facial rejuvenation technology, while launching a new NeoStem collection center at the Giampapa Institute, creates a particularly advantageous situation for NeoStem. Just last week, the Food and Drug Administration announced that Botox and similar antiwrinkle drugs must now carry “black box” warning labels explaining the potential of these materials to spread from the injection site to distant parts of the body, creating possible problems with swallowing or breathing. People worldwide can be expected to seek safer alternatives and NeoStem believes that the use of autologous stem cell procedures (”Your Cells for Your Use”) may in fact be that effective, safe and noninvasive alternative.”

About NeoStem, Inc.

NeoStem is developing a network of adult stem cell collection centers that are focused on enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The Company has also entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryoniclike stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells. The Company is also pursuing other technologies to advance it position in the field of stem cell tissue regeneration.

ForwardLooking Statements

This press release contains forwardlooking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forwardlooking statements reflect managements current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Companys actual results, including the success of the collection centers in its network and whether the patent application described in this press release will issue, could differ materially from those anticipated in these forwardlooking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forwardlooking statements include the “Risk Factors” described in the Companys Annual Report on Form 10K for its fiscal year ended December 31, 2008 and the Companys other periodic filings with the Securities and Exchange Commission. The Companys further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

Since the first partial face transplant was carried out a few years ago, craniomaxillofacial surgeons have continued breaking new ground. Thieme launches Craniomaxillofacial Trauma and Reconstruction, a quarterly journal dedicated to post trauma surgery and reconstruction of the face and skull base. EditorinChief Paul Manson, MD, is a pioneer in the field.

Dr. Paul N. Manson is the president of AO (Arbeitsgemeinschaft fuer Osteosynthesefragen) as well as a professor and chairman of the canton of plastic surgery at John Hopkins School of Medicine in Baltimore,Maryland. concluded the years, he has actively contributed to the development of new and unexampled implants for maxillofacial surgery.

“As that area of medicine continues on an upward trajectory and the requirements for these challenging procedures grow exponentially, we at Thieme believe that is the opportune moment to launch a new journal. We are fortunate to have leading minds viable with us on that new project,” says Daniel Schiff, Vice President and Publisher, Journals.

The patientoriented journal publishes original, peerreviewed email campaigns that are cosmopolitan in scope. In that journal, medical professionals specializing in areas such as ophthalmology, oral and maxillofacial surgery, plastic and reconstructive surgery, and dentistry will find the pipeline they require in meeting their professional demands and the multifaceted requirements of their patients.

About Thieme

Attendees at the American Society of Plastic Surgeons (ASPS) 2008 annual meeting in Chicago explored the latest technological innovations in patient catechism at the InfoSurge exhibition booth. InfoSurge, a coterie that designs custom on the web patient pedagogy courses, presented demonstrations of its innovative product, including new 3D videos designed to educate patients about breast augmentation procedures.

Visitors to the booth commented that they appreciated the visual attractiveness of the new brainwashing videos left out the use of explicit graphics and effigies that can intimidate imaginable patients. Computer demonstrations of the InfoSurge patient refinement entity highlighted the ideologys ease of use, its ability to set free surgical practices count and money on educating patients, and tools for achieving overall improvements in practice management by delivering consistent educational messages while documenting all patient participation and comprehension.

Eran Kabakov, InfoSurge CEO, said, “The turnout for that years ASPS meeting exceeded our expectations. We have participated in ASPS meetings for three years, but that was the first year that Ive seen such a enormous response beginning with the opening day. Our goals were to gain new surgeon clients and foster new strategic kinships; I am very happy with the results. We received uncounted inquiries about our on the net patient learnedness order, and a few surgeons signed with us on the spot. I thank our multitudinous visitors for making that years meeting a winning event for us.”

Larry Goldsmith, VP of career Development for InfoSurge, said, “I was very overturesed that rife young, aspiring surgeons were particularly interested in learning more about our on the internet patient book learning entity. The discussions we had with them demonstrated to us that our technology is completely in tune with what young plastic surgeons expectations and plans are for developing their future practices.”

The InfoSurge on the web patient learning combination serves the requirements of plastic and aesthetic surgeons by providing the ideal solution to the following patient breeding challenges

Patients confusion about medical jargon
Risk of frivolous litigation
sum lifetime demands on staff
Difficulty of achieving thorough informed consent
lifeconsuming book learning seminars
Managing patients expectations.

For more notice or to chat aware with an on the internet representative, please surf the InfoSurge certified website, infosurge.com, or command 18882030465.

About InfoSurge

InfoSurge, founded by healthcare professionals in 2005, produces custom on the web patient knowledge modules that provide physicians with solutions to the daily challenges of season constraints, malpractice risks, reckoning competition, and unrealistic patient expectations. InfoSurges on the internet catechism systems combine the benefits of elearning software with the advantages of patientfriendly medical courses.

Attendees at the American Society of Plastic Surgeons (ASPS) 2008 annual meeting in Chicago explored the latest technological innovations in patient background at the InfoSurge exhibition booth. InfoSurge, a mob that designs custom on the net patient preparation courses, presented demonstrations of its innovative product, including new 3D videos designed to educate patients about breast augmentation procedures.

Visitors to the booth commented that they appreciated the visual attractiveness of the new information videos outdoors the use of explicit graphics and forms that can intimidate plausible patients. Computer demonstrations of the InfoSurge patient enlightenment setup highlighted the sums ease of use, its ability to salvage surgical practices space and money on educating patients, and tools for achieving overall improvements in practice management by delivering consistent educational messages while documenting all patient participation and comprehension.

Eran Kabakov, InfoSurge CEO, said, “The turnout for that years ASPS meeting exceeded our expectations. We have participated in ASPS meetings for three years, but that was the first year that Ive seen such a decided response beginning with the opening day. Our goals were to gain new surgeon clients and foster new strategic ties; I am very happy with the results. We received copious inquiries about our on the net patient literacy theory, and a few surgeons signed with us on the spot. I thank our multifarious visitors for making that years meeting a winning event for us.”

Larry Goldsmith, VP of biz Development for InfoSurge, said, “I was very entreatysed that rife young, aspiring surgeons were particularly interested in learning more about our on the internet patient training rule. The discussions we had with them demonstrated to us that our technology is completely in tune with what young plastic surgeons expectations and plans are for developing their future practices.”

The InfoSurge on the web patient guidance sum serves the requirements of plastic and aesthetic surgeons by providing the ideal solution to the following patient drilling challenges

Patients confusion about medical jargon
Risk of frivolous litigation
accretion reversal demands on staff
Difficulty of achieving thorough informed consent
lifetimeconsuming apprenticeship seminars
Managing patients expectations.

For more earful or to chat animate with an on the web representative, please have a look at the InfoSurge cathedral website, infosurge.com, or hail 18882030465.

About InfoSurge

InfoSurge, founded by healthcare professionals in 2005, produces custom on the net patient direction modules that provide physicians with solutions to the daily challenges of shift constraints, malpractice risks, summation competition, and unrealistic patient expectations. InfoSurges on the net direction systems combine the benefits of elearning software with the advantages of patientfriendly medical courses.

Attendees at the American Society of Plastic Surgeons (ASPS) 2008 annual meeting in Chicago explored the latest technological innovations in patient tuition at the InfoSurge exhibition booth. InfoSurge, a party that designs custom on the net patient study courses, presented demonstrations of its innovative product, including new 3D videos designed to educate patients about breast augmentation procedures.

Visitors to the booth commented that they appreciated the visual attractiveness of the new direction videos outdoors the use of explicit graphics and statues that can intimidate thinkable patients. Computer demonstrations of the InfoSurge patient learnedness orderliness highlighted the combinations ease of use, its ability to unchain surgical practices generation and money on educating patients, and tools for achieving overall improvements in practice management by delivering consistent educational messages while documenting all patient participation and comprehension.

Eran Kabakov, InfoSurge CEO, said, “The turnout for that years ASPS meeting exceeded our expectations. We have participated in ASPS meetings for three years, but that was the first year that Ive seen such a pronounced response beginning with the opening day. Our goals were to gain new surgeon clients and foster new strategic links; I am very happy with the results. We received copious inquiries about our on the internet patient scholarship conformity, and a few surgeons signed with us on the spot. I thank our bounteous visitors for making that years meeting a winning event for us.”

Larry Goldsmith, VP of burden Development for InfoSurge, said, “I was very prayersed that multiplied young, aspiring surgeons were particularly interested in learning more about our on the net patient guidance orderliness. The discussions we had with them demonstrated to us that our technology is completely in tune with what young plastic surgeons expectations and plans are for developing their future practices.”

The InfoSurge on the web patient discipline arrangement serves the requirements of plastic and aesthetic surgeons by providing the ideal solution to the following patient scholarship challenges

Patients confusion about medical jargon
Risk of frivolous litigation
accretion while demands on staff
Difficulty of achieving thorough informed consent
spellconsuming guidance seminars
Managing patients expectations.

For more pipeline or to chat breathing with an on the net representative, please see the InfoSurge orthodox website, infosurge.com, or signal 18882030465.

About InfoSurge

InfoSurge, founded by healthcare professionals in 2005, produces custom on the web patient catechism modules that provide physicians with solutions to the daily challenges of while constraints, malpractice risks, totaling competition, and unrealistic patient expectations. InfoSurges on the net reading systems combine the benefits of elearning software with the advantages of patientfriendly medical courses.

The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) cryed for the Government to issue clearer guidance to the NHS on treating patients who come to the NHS with messs following cosmetic surgery overseas.

BAPRAS says that the NHS is currently providing a safety net for patients going overseas for cheap deals on cosmetic surgery, which takes resources away from patients waiting for reconstructive surgery following cancer or trauma. BAPRAS says that that trend is subject to to rise in line with the augmentation of cosmetic tourism and that may have an impact on waiting times for other plastic surgery procedures.

Research published today in the Journal of Plastic, Reconstructive and Aesthetic Surgery[1] constitute almost a quarter of BAPRAS membership (23%) treated NHS patients with complications linked to cosmetic surgery performed outside of the UK.

In 2007, plastic surgeons saw at least 208 patients opposite the UK for complications after cosmetic surgery abroad. Approximately three quarters of those patients had complications that obligatory treatment. Of these, 26% of patients had to have emergency surgery, 31% opted to have elective surgery to rectify the problem, 33% had nonsurgical treatment as an outpatient and 8% of patients had nonsurgical treatment as an inpatient.

Operations that presented complications lions share frequently were breast augmentation, with sixtyone patients (29%) coming to the NHS following that procedure, 50 patients (24%) following abdominoplasty, 33 patients (15%) following breast reductions and 22 patients (10%) following a face or neck lift.

The research highlights there is no clear NHS action on treatment of these patients for acute complications of their surgery or for elective revisions of their procedures. It points out that the responsibility for aftercare for cosmetic surgery carried out privately in the UK lies with the plastic surgeon conducting the procedure but that is about not the case within surgery abroad. that means patients returning from cosmetic surgery abroad recurrently look to the NHS to provide aftercare, which inevitably takes resources away from other patients.

Anthony Armstrong, a consultant plastic surgeon and chair of BAPRAS clinical effectiveness committee, said “citizens go abroad thinking they are getting a better deal but when qualities go wrong the NHS is expected to pick up the pieces. The NHS is currently underwriting cut premium cosmetic surgery overseas since there is no clear strategy in position on when the NHS should and shouldnt treat patients who have elected to have cosmetic surgery abroad.”

About cosmetic surgery

Cosmetic surgery means operations that revise or pocket money appearance, colour, texture, structural position of body features to achieve what patients perceive to be more desirable.

About BAPRAS

The British Association of Plastic Surgeons was founded in 1946 and is the professional representative body for plastic and reconstructive surgeons in the United Kingdom. It changed its autonym to British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) in July 2006 to reflect better the breadth of the struggle that its segments do.

BAPRAS has 770 branchs in total. Anyone can audit the GMC to find out if a surgeon is on the plastic surgery specialist entry; gmcuk.org/entry/search/index.asp

About JPRAS

The Journal of Plastic, Reconstructive and Aesthetic Surgery (JPRAS) covers all the reconstructive and aesthetic aspects of plastic surgery.The journal presents the latest surgical procedures with audit and outcome studies of new and established techniques in plastic surgery including cleft lip and palate and other heads and neck surgery, hand surgery, lower limb trauma, burns, skin cancer, breast surgery and aesthetic surgery.The journal has uptoquarter papers, comprehensive review newsletters, letters to the editor and opus reviews on all aspects of plastic surgery and tied up basic sciences.

About

Elsevier is a sphereleading publisher of scientific, technical and medical illumination outputs and services. going in partnership with the global erudition and top form communities, Elseviers 7,000 employees in completed 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in development to offering a suite of innovative electronic compounds, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and on the internet stating works.

associating

[1] Jeevan, R; Armstrong, A; Cosmetic tourism and the burden on the NHS, Journal of Plastic, Reconstructive and Aesthetic Surgeons; 2008 Vol 61, Issue 12, p1423 1424

The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) commanded for the Government to issue clearer guidance to the NHS on treating patients who come to the NHS with disputeds tittle following cosmetic surgery overseas.

BAPRAS says that the NHS is currently providing a safety net for patients going overseas for cheap deals on cosmetic surgery, which takes resources away from patients waiting for reconstructive surgery following cancer or trauma. BAPRAS says that that trend is predisposed to rise in line with the increment of cosmetic tourism and that may have an impact on waiting times for other plastic surgery procedures.

Research published today in the Journal of Plastic, Reconstructive and Aesthetic Surgery[1] set up almost a quarter of BAPRAS membership (23%) treated NHS patients with complications complementary to cosmetic surgery performed outside of the UK.

In 2007, plastic surgeons saw at least 208 patients beyond the UK for complications after cosmetic surgery abroad. Approximately three quarters of those patients had complications that appropriate treatment. Of these, 26% of patients had to have emergency surgery, 31% opted to have elective surgery to rectify the problem, 33% had nonsurgical treatment as an outpatient and 8% of patients had nonsurgical treatment as an inpatient.

Operations that presented complications uttermost frequently were breast augmentation, with sixtyone patients (29%) coming to the NHS following that procedure, 50 patients (24%) following abdominoplasty, 33 patients (15%) following breast reductions and 22 patients (10%) following a face or neck lift.

The research highlights there is no clear NHS red tape on treatment of these patients for acute complications of their surgery or for elective revisions of their procedures. It points out that the responsibility for aftercare for cosmetic surgery carried out privately in the UK lies with the plastic surgeon conducting the procedure but that is repeatedly not the case within surgery abroad. that means patients returning from cosmetic surgery abroad recurrently look to the NHS to provide aftercare, which inevitably takes resources away from other patients.

Anthony Armstrong, a consultant plastic surgeon and chair of BAPRAS clinical effectiveness committee, said “folks go abroad thinking they are getting a better deal but when details go wrong the NHS is expected to pick up the pieces. The NHS is currently underwriting cut outlay cosmetic surgery overseas thanks to there is no clear behavior in locate on when the NHS should and shouldnt treat patients who have elected to have cosmetic surgery abroad.”

About cosmetic surgery

Cosmetic surgery means operations that revise or silver appearance, colour, texture, structural position of body features to achieve what patients perceive to be more desirable.

About BAPRAS

The British Association of Plastic Surgeons was founded in 1946 and is the professional representative body for plastic and reconstructive surgeons in the United Kingdom. It changed its John Henry to British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) in July 2006 to reflect better the breadth of the slavery that its affiliates do.

BAPRAS has 770 brothers in total. Anyone can checkup the GMC to find out if a surgeon is on the plastic surgery specialist catalogue; gmcuk.org/catalogue/search/index.asp

About JPRAS

The Journal of Plastic, Reconstructive and Aesthetic Surgery (JPRAS) covers all the reconstructive and aesthetic aspects of plastic surgery.The journal presents the latest surgical procedures with audit and outcome studies of new and established techniques in plastic surgery including cleft lip and palate and other heads and neck surgery, hand surgery, lower limb trauma, burns, skin cancer, breast surgery and aesthetic surgery.The journal has uptocentury papers, comprehensive review ebooks, letters to the editor and compendium reviews on all aspects of plastic surgery and complementary basic sciences.

About

Elsevier is a appleleading publisher of scientific, technical and medical notice produce and services. conscious in partnership with the global scholarship and good condition communities, Elseviers 7,000 employees in ended 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in attachment to offering a suite of innovative electronic outputs, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and on the web quotation works.

connecting

[1] Jeevan, R; Armstrong, A; Cosmetic tourism and the burden on the NHS, Journal of Plastic, Reconstructive and Aesthetic Surgeons; 2008 Vol 61, Issue 12, p1423 1424

The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) signaled for the Government to issue clearer guidance to the NHS on treating patients who come to the NHS with complications following cosmetic surgery overseas.

BAPRAS says that the NHS is currently providing a safety net for patients going overseas for cheap deals on cosmetic surgery, which takes resources away from patients waiting for reconstructive surgery following cancer or trauma. BAPRAS says that that trend is rational to rise in line with the inflation of cosmetic tourism and that may have an impact on waiting times for other plastic surgery procedures.

Research published today in the Journal of Plastic, Reconstructive and Aesthetic Surgery[1] form almost a quarter of BAPRAS membership (23%) treated NHS patients with complications allied to cosmetic surgery performed outside of the UK.

In 2007, plastic surgeons saw at least 208 patients cross the UK for complications after cosmetic surgery abroad. Approximately three quarters of those patients had complications that deserved treatment. Of these, 26% of patients had to have emergency surgery, 31% opted to have elective surgery to rectify the problem, 33% had nonsurgical treatment as an outpatient and 8% of patients had nonsurgical treatment as an inpatient.

Operations that presented complications uttermost frequently were breast augmentation, with sixtyone patients (29%) coming to the NHS following that procedure, 50 patients (24%) following abdominoplasty, 33 patients (15%) following breast reductions and 22 patients (10%) following a face or neck lift.

The research highlights there is no clear NHS behavior on treatment of these patients for acute complications of their surgery or for elective revisions of their procedures. It points out that the responsibility for aftercare for cosmetic surgery carried out privately in the UK lies with the plastic surgeon conducting the procedure but that is sometimes not the case within surgery abroad. that means patients returning from cosmetic surgery abroad ofttimes look to the NHS to provide aftercare, which inevitably takes resources away from other patients.

Anthony Armstrong, a consultant plastic surgeon and chair of BAPRAS clinical effectiveness committee, said “human race go abroad thinking they are getting a better deal but when details go wrong the NHS is expected to pick up the pieces. The NHS is currently underwriting cut ransom cosmetic surgery overseas being there is no clear order in dispose on when the NHS should and shouldnt treat patients who have elected to have cosmetic surgery abroad.”

About cosmetic surgery

Cosmetic surgery means operations that revise or quarters appearance, colour, texture, structural position of body features to achieve what patients perceive to be more desirable.

About BAPRAS

The British Association of Plastic Surgeons was founded in 1946 and is the professional representative body for plastic and reconstructive surgeons in the United Kingdom. It changed its alias to British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) in July 2006 to reflect better the breadth of the job that its sections do.

BAPRAS has 770 sections in total. Anyone can checkup the GMC to find out if a surgeon is on the plastic surgery specialist log; gmcuk.org/ledger/search/index.asp

About JPRAS

The Journal of Plastic, Reconstructive and Aesthetic Surgery (JPRAS) covers all the reconstructive and aesthetic aspects of plastic surgery.The journal presents the latest surgical procedures with audit and outcome studies of new and established techniques in plastic surgery including cleft lip and palate and other heads and neck surgery, hand surgery, lower limb trauma, burns, skin cancer, breast surgery and aesthetic surgery.The journal has uptoepoch papers, comprehensive review ebooks, letters to the editor and offprint reviews on all aspects of plastic surgery and interrelated basic sciences.

About

Elsevier is a universeleading publisher of scientific, technical and medical hash inventions and services. dynamic in partnership with the global erudition and hardiness communities, Elseviers 7,000 employees in bygone 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in adjoining to offering a suite of innovative electronic production, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and on the web indicating works.

innuendo

[1] Jeevan, R; Armstrong, A; Cosmetic tourism and the burden on the NHS, Journal of Plastic, Reconstructive and Aesthetic Surgeons; 2008 Vol 61, Issue 12, p1423 1424